![Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology](https://onlinelibrary.wiley.com/cms/asset/fec1e2e8-1746-4367-ab4d-0b1d79098e29/jdv17623-fig-0001-m.jpg)
Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology
![Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/88/3/173/F1.large.jpg)
Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine
![Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00448-x/MediaObjects/13555_2020_448_Fig1_HTML.jpg)